Flumist Quadrivalent
Payments companies reported to CMS as associated with Flumist Quadrivalent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Flumist Quadrivalent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Flumist Quadrivalent
These are the largest totals companies reported as associated with Flumist Quadrivalent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ravi Jhaveri | Chicago, IL | Pediatric Infectious Diseases | $13,257.08 |
| Philip Boucher | Omaha, NE | Pediatrics | $10,290.00 |
| Myron Levin | Aurora, CO | Pediatric Infectious Diseases | $5,772.75 |
| Philip Dormitzer | Boston, MA | Internal Medicine | $5,250.00 |
| Janet Englund | Seattle, WA | Pediatric Infectious Diseases | $4,600.00 |
| Neil Skolnik | Jenkintown, PA | Family Medicine | $3,222.00 |
| Michael Decker | Baxter, TN | Infectious Disease | $3,071.25 |
| James Antoon | Nashville, TN | Hospitalist | $2,047.50 |
| Charlotte Hobbs | Birmingham, AL | Pediatric Infectious Diseases | $2,047.50 |
| Stanley Grogg | Tulsa, OK | Pediatrics | $1,912.50 |
Prescribed Flumist Quadrivalent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.